Carsten Brunn

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RNAC

Current role

CEO, Board Member

2018-01-01–present

1 call Latest call 2025-05-08

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Cartesian Therapeutics, Inc. (RNAC)	President and Chief Executive Officer	$674,000	—	$973,475	$2,314,320	$363,960	$4,113	$4,329,868
2024	Cartesian Therapeutics, Inc. (RNAC)	President and Chief Executive Officer	$642,720	—	$3,071,706	$3,138,074	$459,545	$2,166	$7,314,211
2023	Cartesian Therapeutics, Inc. (RNAC)	President and Chief Executive Officer	$618,228	$1,323,000	$319,564	$1,123,658	$343,200	$2,384,233	$6,111,883
2022	Cartesian Therapeutics, Inc. (RNAC)	President and Chief Executive Officer	$588,043	—	$749,053	$2,628,525	$325,655	$966	$4,292,242
2021	Cartesian Therapeutics, Inc. (RNAC)	President and Chief Executive Officer	$569,003	—	$720,529	$2,067,782	$313,115	$966	$3,671,395
2020	Cartesian Therapeutics, Inc. (RNAC)	President and Chief Executive Officer	$550,000	$50,000	—	$1,178,324	$316,250	$773	$2,095,347
2019	Cartesian Therapeutics, Inc. (RNAC)	President and Chief Executive Officer	$550,000	—	—	$1,043,972	$275,000	$117,523	$1,986,495
2018	Cartesian Therapeutics, Inc. (RNAC)	President and Chief Executive Officer	$42,308	$97,917	$1,055,250	$4,403,673	—	$6,000	$5,605,148

Earnings-call appearances and filed executive appointments or departures, newest first.